poLight (PLT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Achieved design-wins with Vuzix Shield AR smart glasses and received significant technical sample and purchase orders from major AR/MR OEMs, indicating strong market interest.
Rights issue completed, raising NOK 124 million net proceeds and strengthening the balance sheet.
New CFO appointed and amendments made to the share option plan.
Wooptix launched a wavefront phase camera using TLens®, and new barcode scanning orders were secured.
Completed a successful Capital Markets Day, highlighting deep dives into the value chain and strong stakeholder engagement.
Financial highlights
Q2 2024 revenue was NOK 5.3 million, down from NOK 7.2 million in Q2 2023.
EBITDA loss increased to NOK 21.7 million from NOK 18.0 million year-over-year, mainly due to higher inventory obsolescence provisions and higher personnel costs.
Cash and cash equivalents at quarter-end were NOK 199.3 million, up from NOK 114.8 million at year-end 2023, supported by the rights issue.
Inventory decreased to NOK 64.8 million from NOK 70.1 million at year-end 2023, reflecting increased obsolescence provisions.
Gross profit in Q2 2024 was NOK 2.0 million, down from NOK 3.7 million in Q2 2023.
Outlook and guidance
AR/MR market outlook is promising, with poLight AF solutions used in four commercial products and growing interest from consumer OEMs.
Consumer-related device activity is increasing globally, and the company is well-positioned in the AR/MR autofocus segment.
Smartphone market remains challenging, but initiatives are underway to make TLens® more price-competitive and suitable for back cameras.
Industrial and scientific markets are gradually revealing more opportunities, with poLight's reputation strengthening.
Company expects continued progress in strategic segments and is strengthening its portfolio and organization.
Latest events from poLight
- AR/MR and TWedge segments show strong momentum, with investments supporting future growth.PLT
Investor update2 Mar 2026 - Record Q4 revenue and strong AR/MR momentum, with 60% gross margin and robust cash reserves.PLT
Q4 202524 Feb 2026 - AR/MR and industrial momentum grew despite lower revenue; liquidity boosted by rights issue.PLT
Q1 202431 Jan 2026 - AR/MR and consumer markets prioritized, with new tech and strong pipeline driving growth from 2026.PLT
CMD 202431 Jan 2026 - Revenue fell, but AR/MR and healthcare pipelines grew, backed by strong cash reserves.PLT
Q3 202417 Jan 2026 - Expanding in AR/MR and consumer markets, with strong tech and strategic customer engagement.PLT
Investor Update12 Jan 2026 - AR/MR and industrial segments show strong momentum, with robust financials and expanding PoCs.PLT
Investor Update26 Dec 2025 - Q1 2025 revenue climbed, losses widened, and Q Tech investment boosts AR/MR prospects.PLT
Q1 202523 Dec 2025 - Tunable lens tech gains traction in AR/MR, with strong consumer pipeline and strategic backing.PLT
ABGSC Investor Days4 Dec 2025